Copyright 2008 Medical News Today Latest Dermatology News From Medical News Today. http://www.medicalnewstoday.com/sections/dermatology/ admin@medicalnewstoday.com (MNT Admin) editors@medicalnewstoday.com (MNT Editors) en-us Thu, 24 Jul 2008 02:00:00 PDT http://www.medicalnewstoday.com/articles/115958.php Dr. Michael Law, a board certified plastic surgeon in Raleigh, North Carolina, sees patients from all parts of the world seeking natural looking plastic surgery. "Fat grafting has changed the results of facial plastic surgery dramatically. Traditional facelifts simply do not provide the natural result of microfat grafting," says Dr. Law. Fat grafting has been performed by plastic surgeons for decades. Thu, 24 Jul 2008 02:00:00 PDT http://www.medicalnewstoday.com/articles/115955.php PhiloGene, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to VEGFb for the treatment of patients with advanced melanoma. This approval is for a larger subset of melanoma patients than was requested, and includes melanoma in stages IIb through IV. Wed, 23 Jul 2008 00:00:00 PDT http://www.medicalnewstoday.com/articles/115821.php A study published in the July/August issue of Archives of Facial Plastic Surgery finds that carbon dioxide laser resurfacing is an effective long-term treatment for facial wrinkles. In carbon dioxide laser resurfacing, a laser blasts water molecules inside and outside of cells, which vaporizes the water and causes heat damage to the surrounding tissue. Wed, 23 Jul 2008 00:00:00 PDT http://www.medicalnewstoday.com/articles/115774.php A senior lecturer at the University of Huddersfield recently celebrated the publication of her first book. Dr Karen Ousey, of the Department of Adult and Children's Nursing in the School of Human and Health Sciences, co-edited the textbook with former Huddersfield academic Dr. Tue, 22 Jul 2008 02:00:00 PDT http://www.medicalnewstoday.com/articles/115706.php Burns in children are a complex and all-too common injury requiring coordinated care to achieve good medical, functional, and psychological outcomes. A thorough update in a wide range of areas affecting treatment and rehabilitation for "The Burned Child" is presented in a special topic section of the July Journal of Craniofacial Surgery. Tue, 22 Jul 2008 01:00:00 PDT http://www.medicalnewstoday.com/articles/115667.php Helicon Group Limited (ASX:HCG) is pleased to announce that earlier this month the Chinese State Food and Drug Administration (SFDA) granted approval for the skin regeneration concept and device, ReCell(R), for sale in China. The approval process for the product has been complicated and intensive due in part to the pioneering nature and complexity of the ReCell(R) kit. Importation issues with some components of the kit are being resolved with the SFDA. Tue, 22 Jul 2008 00:00:00 PDT http://www.medicalnewstoday.com/articles/115665.php According to a new study published in the July issue of Archives of Dermatology, more women than men are coming to dermatology clinics to have their tattoos removed. Removals are often driven by a desire to avoid the social stigma associated with tattoos, and many seek removal due to negative comments made by other. A recent survey has found that 25% of adults age 18 to 30 have at least one tattoo. Mon, 21 Jul 2008 01:00:00 PDT http://www.medicalnewstoday.com/articles/115603.php GPs risk legal action if they fail to follow GMC guidance - as well as NICE guidelines - when they treat skin cancers, warns the Medical and Dental Defence Union of Scotland (MDDUS) today (Wednesday, 16 July 2008). GMC guidance in Good Medical Practice advises doctors to "recognise and work within the limits of [their] competence". The GMC also advises: "You should be familiar with relevant guidelines and developments that affect your work. Mon, 21 Jul 2008 00:00:00 PDT http://www.medicalnewstoday.com/articles/115597.php In a groundbreaking study involving 75 African American patients, Dr. Oleh Slupchynskyj, Founder and Director of The Aesthetic Facial Surgery Institute of New York and New Jersey, statistically proves a unique three-tiered surgical approach in rhinoplasty results in an excellent degree of preservation of ethnic characteristics, very high patient satisfaction postoperatively and consistently increased self-esteem. Fri, 18 Jul 2008 04:00:00 PDT http://www.medicalnewstoday.com/articles/115493.php University of Rochester Medical Center researchers found a new protein produced excessively in malignant melanoma, a discovery that is particularly relevant as skin cancer rates climb dramatically among young women. The protein, IMP-3, is not over-expressed in harmless moles but is increased in the most dangerous types of skin cancer, and in a subset of lesions that can be difficult to predict called thin melanomas. Fri, 18 Jul 2008 03:00:00 PDT http://www.medicalnewstoday.com/articles/115472.php Galderma Pharma S.A., a global specialty pharmaceutical company focused on dermatology, has announced that Japan's Ministry of Health, Labor and Welfare has approved Differin® Gel 0.1% (adapalene), a novel topical treatment for acne vulgaris in Japan. The drug will be marketed in Japan by Galderma KK, the fully-owned Japanese arm of Galderma, and strategic alliance partner Shionogi. Fri, 18 Jul 2008 01:00:00 PDT http://www.medicalnewstoday.com/articles/115388.php Children aged 4 and younger were hospitalized with skin infections more than 34,000 times in 2006, a 150 percent increase from 2000, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. The data are included in a new AHRQ analysis of hospitalization trends among children 17 and younger. It shows skin infections ranked as the 8th most common reason for child hospitalizations in 2006, up from 17th in 2000. Wed, 16 Jul 2008 01:00:00 PDT http://www.medicalnewstoday.com/articles/115099.php Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Company"), a development-stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic-resistant infections, announced the initiation of a Phase 2 clinical trial for an intravenous form of antibiotic compound RX-3341 in the treatment of complicated skin and skin structure infections (cSSSIs). The safety and efficacy study will be conducted at 35 sites across the United States. Tue, 15 Jul 2008 03:00:00 PDT http://www.medicalnewstoday.com/articles/115024.php Medspas of America Inc. (PINKSHEETS: MEDP), http://www.medspasofamerica.com. Two important clinical tests and nine additional clinical observations have been completed on Penzyme, leading to extremely favorable results and excellent news for Medspas. Penzim is the active and main ingredient in its Natural Renu anti-aging cream and gel. Tue, 15 Jul 2008 01:00:00 PDT http://www.medicalnewstoday.com/articles/114950.php Sunning in the summer feels oh-so-good. But ultraviolet A (UVA) and ultraviolet B (UVB) light damage the skin and increase the risk of skin cancer. Sun exposure is the most preventable risk factor for all skin cancers, including melanoma. UV exposure even when no sunburn occurs increases the risk of cancer. Savvy use of sunscreen reduces the risk of damage from the sun's harmful rays. Tue, 15 Jul 2008 01:00:00 PDT http://www.medicalnewstoday.com/articles/114938.php A newly available treatment already has benefited several individuals with aggressive malignancies. Offered through NeoPlas Innovation, this regimen has arrested or eradicated tumors in more than 80% of initial patients. Director of Research Dr. Stephen Cantrell emphasized that human testing is in its early stages, but added, "These results have surprised us. This is far beyond what currently available standard treatments achieve. Tue, 15 Jul 2008 00:00:00 PDT http://www.medicalnewstoday.com/articles/114932.php A standardized 60-second hair count is a reliable method when assessing hair shedding, according to an article released on June 16, 2008 in the Archives of Dermatology, one of the JAMA/Archives journals. According to the study, assessment of shedding, as opposed to baldness, is not standardized across the medical profession. Sat, 12 Jul 2008 00:00:00 PDT http://www.medicalnewstoday.com/articles/114772.php Schering-Plough (NYSE: SGP) and the EORTC announced that long-term treatment with pegylated interferon alfa-2b in stage III melanoma patients had a significant and sustained impact on relapse-free survival (RFS), according to results of a randomized phase III trial published in The Lancet. Fri, 11 Jul 2008 12:00:00 PDT http://www.medicalnewstoday.com/articles/114770.php A review of 30 years of surveillance and epidemiological records shows that incidence of melonoma, the most lethal form of skin cancer, is increasing among young Caucasian women but not among young men in the US. The reviewers did not establish if this is due to increased exposure to ultraviolet radiation or some other factor and suggested this should be investigated further. Fri, 11 Jul 2008 00:00:00 PDT http://www.medicalnewstoday.com/articles/114591.php Opticom Data Research performs skin mole analysis on mole images that are submitted through its Web site. The company uses its MoleSense software to analyze these moles and then an automated process compares the analysis results to 100s of skin cancer images available on the Internet. This is a new service by Opticom Data Research. A report is emailed to the individual who submitted the mole image. Thu, 10 Jul 2008 00:00:00 PDT http://www.medicalnewstoday.com/articles/114282.php Several specific risk factors have been identified in the recurrence or spreading of cutaneous squamous-cell carcinoma, or skin cancer. These factors, released on July 9, 2008 in The Lancet Oncology, include: a tumor thickness of 6.0 mm or more, desmoplastic growth, location at the ear, and immune suppression. Squamous-cell carcinomas (SCCs) are some of the most likely cancers to metastasize or spread. Wed, 09 Jul 2008 15:00:00 PDT http://www.medicalnewstoday.com/articles/114381.php MISSION Product™, the first Athlete-Engineered Skincare™ line, congratulates five of its athletes as they prepare to represent the United States in Beijing this summer. Only three months after joining forces to help launch MISSION Product, a line of high-performance skincare products specifically designed by athletes to meet athletic needs, U.S. Wed, 09 Jul 2008 04:00:00 PDT http://www.medicalnewstoday.com/articles/114393.php ALIGN Pharmaceuticals, LLC, a wholly owned subsidiary of Cyclacel Pharmaceuticals, Inc., (NASDAQ: CYCC, CYCCP) announced results of a double-blinded, randomized, vehicle-controlled clinical study showing that Xclair® cream (formerly MAS065D) is safe and effective in the treatment and prevention of radiation dermatitis. These results were published in the May-June 2008 issue of the European Journal of Dermatology. Wed, 09 Jul 2008 01:00:00 PDT http://www.medicalnewstoday.com/articles/114306.php The European Commission announced a new 50mg Enbrel® (etanercept) once weekly dosage regimen as an alternative to the currently approved 25mg Enbrel® twice weekly regimen for the treatment of patients with moderate-to-severe plaque psoriasis. Based on the outcome of the extensive European 318 study in adult patients with moderate-to-severe plaque psoriasis, the European Commission issued the marketing authorisation for the European Union for a once weekly 50mg Enbrel® dosing. Wed, 09 Jul 2008 00:00:00 PDT http://www.medicalnewstoday.com/articles/114273.php An analysis of more than 100 patients has confirmed for the first time that darker-skinned patients benefit as those with lighter skin when given light therapy for morphea and related diseases, UT Southwestern Medical Center researchers show. Phototherapy is the use of ultraviolet light to treat skin disorders, ranging from common problems such as acne and psoriasis to rarer conditions such as scleroderma and morphea, a hardening of the skin.